![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | April 2022
The Supreme Court has dealt a blow to self-invested pension plans (SIPPs) by denying permission to appeal in the Carey SIPP case.
Last year the Court of Appeal gave a member-friendly ruling in the case of Adams v Options UK Personal Pensions LLP (formerly known as Carey Pensions). The effect is that a SIPP provider can be held liable if an unregulated introducer is involved in a member’s decision to transfer to a SIPP and in the process breaches financial services laws by giving advice or making arrangements without the necessary authorisation.
This refusal by the Supreme Court to hear an appeal means that this is the end of the road for Options Pensions which reportedly has a large number of claims similar to the Mr Adams complaint outstanding. More widely this development means that it will continue to be risky for SIPP providers to accept business from unregulated introducers.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023